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Abstract 
Disgust-driven stigma may be motivated by an assumption that a stigmatized target presents a 
disease threat, even in the absence of objective proof.  Accordingly, even non-contagious 
diseases, such as cancer, can become stigmatized by eliciting disgust.  This study had two 
parts: a survey (n = 272), assessing the association between disgust traits and cancer stigma; 
and an experiment, in which participants were exposed to a cancer surgery (n = 73) or neutral 
video (n = 68), in order to test a causal mechanism for the abovementioned association.  
Having a higher proneness to disgust was associated with an increased tendency to stigmatize 
people with cancer.  Further, a significant causal pathway was observed between disgust 
propensity and awkwardness- and avoidance-based cancer stigma via elevated disgust 
following cancer surgery exposure.  In contrast, those exposed to cancer surgery not 
experiencing elevated disgust reported less stigma than controls.  Exposure-based 
interventions, which do not elicit disgust, may be profitable in reducing cancer stigma.   
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Introduction 
Health- or illness-related stigma can be conceptualised as a complex process 
involving exclusion, rejection, blame, or devaluation towards an individual or group 
perceived as “different” as a function of their health status (Marlow & Wardle, 2014).  
Stigma in chronic diseases, such as cancer, can have powerful detrimental effects on an 
individual’s psychological health through, for example, a heightened vulnerability to negative 
self-identification (e.g., Rosman, 2004), loss of emotional support (e.g., Bloom & Kessler, 
1994), and increased psychological distress (e.g., Quinn, & Chaudoir, 2009).  Stigma also 
may have direct adverse consequences on patients’ physical health, and is associated with an 
increased risk of poor physical health outcomes (e.g., Cho et al., 2004).  Stigma may 
discourage individuals from being tested or treated for the stigmatised disease or condition 
(e.g., Courtwright, 2009), cause diagnostic delay (e.g., Tod, Craven, & Allmark, 2008), 
and/or treatment discontinuation (e.g., Sirey et al., 2001).   
The effects of health-related stigma can be particularly difficult for those with chronic 
diseases (Link & Phelan, 2006), such as cancer.  Stigma has been shown to be one of the 
difficulties and challenges that cancer patients confront more often than some other illness 
groups (e.g., including diabetes, heart disease, and stroke; Albrecht, Walker, & Levy 1982; 
Berman, & Wandersman, 1990).  The strong and pervasive stigmatization of cancer patients 
may be due to the visible differences produced by cancer symptoms and the side-effects of 
treatment (e.g., hair loss and disfigurement; Costa, Nogueira, de Souza Lima, Mendonça, & 
Leles, 2014; Powell, Azlan, Simpson, & Overton, 2016; Rosman, 2004).  Other contributory 
factors include cancer’s association with death and mortality (Knapp, Marziliano, & Moyer, 
2014), and the belief that cancer is associated with, or caused by, patients’ behaviour (e.g., 
via a risky lifestyle; Threader, & McCormack, 2016).  The serious impacts of stigma 
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underpin the aim of this paper, which is to explore the role of disgust, a health-related 
emotion, in stigma towards people with cancer. 
Disgust – the Disease Avoidance Emotion 
Disgust is a universal human emotion (Ekman, 1992) that appears to have evolved 
primarily to motivate humans to avoid disease and maintain good health (Consedine & 
Moskowitz, 2007; Oaten, Stevenson & Case, 2009).  It is an extended form of the sensation 
of distaste, which guards against the consumption of potentially harmful substances (Rozin & 
Fallon, 1987), and evolved into an emotion that protects the body border against broader (i.e., 
non-oral) pathogenic threats (Curtis, Aunger, & Rabie, 2004).  The disgust emotion has since 
been co-apted to promote the condemnation, avoidance, and rejection of certain sociomoral 
transgressions (e.g., violations of purity norms; Chapman & Anderson, 2012). 
Known as the “disease-avoidance emotion” (Curtis, de Barra, & Aunger, 2011), 
disgust has been argued to be the affective component of humans’ “behavioural immune 
system” (Stevenson, Case, & Oaten, 2009), which motivates avoidance of stimuli that might 
result in illness or contamination (Neuberg, Kenrick, & Schaller, 2011; Schaller & Park, 
2011).  People report much greater disgust to stimuli linked to disease transmission, for 
example (Curtis et al., 2004).  As a protector of health, however, the disgust response is to 
some extent imprecise and causes false alarms, where the perceptions of a threat to health can 
occur (or persist) in the absence of an objective threat (e.g., Nemeroff, & Rozin, 1994; 
Reynolds, Consedine, Pizarro, & Bissett, 2013).  Stimuli that either have been in contact 
with, or imitate features of, stimuli that could make us unwell can elicit disgust (i.e., the “law 
of contagion” and “law of similarity”; Rozin, Haidt, McCauley, Dunlop, & Ashmore, 1999).  
Thus, while many people with infectious diseases are more prone to being stigmatized 
(Schaller, 2011), this effect extends to non-contagious diseases, including cancer (Fife & 
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Wright, 2000), that mimic the signs of infectious disease (e.g., via distinguishing features 
such as hair loss, handicap, etc.; Goffman, 1963; Rosman, 2004). 
Disgust and Disease Stigma 
Research has revealed that disgust reactions may be predictive of stigma.  Disgust 
propensity (DP), an individual’s underlying proneness to be disgusted (van Overveld, de 
Jong, Peters, Cavanagh, & Davey, 2006), has been found to have a significant link with 
negative attitudes toward obese people (e.g., Vartanian, 2010), and is associated with greater 
prejudice and stigma towards homosexuality (e.g., Inbar, Pizarro, Knobe, & Bloom, 2009; 
Olatunji, 2008).  Disgust propensity has also been found to demonstrate positive correlations 
with negative outgroup evaluations (e.g., Hodson et al., 2013; Navarrete & Fessler, 2006) and 
opposition to immigration (e.g., Aarøe, Petersen, & Arceneaux, 2017).  Previous work has 
also linked DP to wanting less contact with non-cancer specific colostomy patients and with 
self-perceived stigma (e.g., Smith, Loewenstein, Rozin, Sherriff, & Ubel, 2007).  Moreover, a 
complementary body of experimental research has demonstrated causal effects of disgust on 
avoidance (a behavioural component of stigma) in relevant health contexts.  These include 
avoidance and delay of help-seeking for colorectal cancer (Reynolds, McCambridge, Bissett, 
& Consedine, 2014) and sexual health (McCambridge & Consedine, 2014) symptoms, and a 
disgust-induced social avoidance of people with bowel problems (Reynolds, Lin, Zhou, & 
Consedine, 2015). 
Only minimal research, however, has explored disgust as a predictor of stigma 
towards chronic diseases, such as cancer, directly, and much of this is cross-sectional survey 
work, making it difficult to determine the causal relationship between disgust and stigma.  
Perhaps the closest prior work is by Pryor, Reeder, Yeadon, and Hesson-McInnis (2004).  As 
part of a wider investigation, Pryor et al. (2004) showed that DP was associated with 
avoidance reactions to a composite of stigmatized health conditions, including HIV, AIDS, 
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obesity, and cancer, in a computerised behavioural task.  However, individual effects on 
cancer were not explored in this study.  Furthermore, the study did not include an 
experimental manipulation, control for bidirectional effects of existing stigma responses on 
disgust, or test a causal mechanism for the findings.  Accordingly, the causal role that disgust 
traits may have in predicting the stigmatization of people with cancer (i.e., via heightened 
state disgust reactions) remains to be empirically demonstrated.  Given that stigma is 
complex and has multiple correlates, there is a need for more experimental studies to 
illuminate causality here (e.g., Reynolds, McCambridge et al., 2014; Reynolds, Lin et al., 
2015).  In this paper, we are interested in modelling a causal pathway, from trait disgust to 
state disgust reactions to cancer stigma, using complementary survey and experimental 
exposure methods. 
A final oversight in prior work is a focus on DP at the expense of other sorts of 
systematic individual differences in responses to disgust stimuli.  In particular, as well as DP, 
individuals show variation in disgust sensitivity (DS; how unpleasant the experience of 
disgust is to the individual, Curtis et al., 2011).  To the authors’ knowledge, DS has not yet 
been assessed in relation to stigma.  Therefore, assessing disgust sensitivity alongside DP in 
the current research is of importance for at least two reasons.  First, DP and DS are correlated 
traits (van Overveld et al., 2006), and previous studies that have estimated the effects of DP 
in the absence of DS may have overestimated the unique contribution of the former in its 
relationship with stigma.  Second, while possessing high levels of either of the disgust traits 
may have a causal role in increasing cancer stigma by influencing the frequency and/or 
intensity of state disgust reactions (e.g., Deacon & Olatunji, 2007), it is possible that DP and 
DS may have differential effects on cancer stigma, with one being more important than the 
other (see e.g., Azlan, Overton, Simpson, & Powell, 2017).  This issue is thus worthy of 
investigation.  
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The Current Report 
Despite the compelling rationale outlined above, there has been relatively little 
research into the role of disgust traits and stigma in cancer.  Furthermore, the direction and 
nature of causality in the relationship is unclear, that is, if disgust traits cause increased 
stigma or if the reverse is true, promoting a need for experimental work.  In the present paper, 
we tested the link between disgust traits and multifaceted cancer stigma in a two-phase study, 
with a survey and experimental component.  Phase 1 was an exploratory study designed to 
establish the links between dispositional disgust traits (DP and DS) and several dimensions of 
stigma towards people with cancer.  Phase 2 was designed to examine a potential causal 
mechanism (state disgust) between disgust traits and awkwardness- and avoidance-based 
cancer stigma, through an experimental study.  In particular, following prior work that has 
demonstrated a moderating role for trait disgust on people’s disgust-related responding (e.g., 
Fleischman, Hamilton, Fessler, & Meston, 2015; Reynolds, McCambridge et al., 2014), we 
wanted to test whether people more prone (or sensitive) to disgust would respond with greater 
disgust in response to cancer-relevant disgust-eliciting stimuli and whether this would lead to 
greater stigma.  Four main predictions were tested:  
Predictions for Phase 1 (Survey) 
(1) Based on past research (e.g., Inbar et al., 2009; Olatunji, 2008; Vartanian, 2010), we 
hypothesized that individuals with a higher DP would report greater stigma towards 
people with cancer.  No prior work has investigated the effect of DS on stigma; 
however, given its association with DP, we hypothesised that this would be associated 
with greater cancer stigma. 
(2) We also explored the non-directional hypothesis that the size of the associations 
between DP and stigma and DS and stigma would differ significantly.   
Predictions for Phase 2 (Experimental) 
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(3) We hypothesised that exposure to disgust-eliciting cancer-relevant stimuli (i.e., 
watching a cancer surgery video) would invoke greater disgust than neutral (control) 
stimuli, which would lead to increased avoidance- (e.g., Curtis et al., 2011) and 
awkwardness- (e.g., Reynolds, McCambridge, & Consedine, 2015) based cancer 
stigma responses.   
(4) Combining (1) and (3), we predicted that DP and DS would have a causal effect on 
avoidance- and awkwardness-based stigma by moderating (increasing) the effect of 
the cancer video on state disgust.  
Phase 1 – Survey Study 
Methods 
Participants 
Two hundred and seventy-two participants were opportunity sampled online.  Most 
participants were women (n = 196), with ages ranging from 18 to 67 years (M = 26.72, SD = 
10.71).  No participants reported having had a diagnosis of cancer.  The participants were 
recruited from the host university’s volunteers list and adverts on several online recruitment 
pages, including “Call for Participants” (https://callforparticipants.com) and “Psychology 
Research on the Net” (https://psych.hanover.edu/research/exponnet.html).  As many 
participants as possible were recruited within the study recruitment window.  Using G*Power 
3.1.9.4 (Faul, Erdfelder, Lang, & Buchner, 2007), a post hoc power analysis showed that a 
sample of 272 participants had 75% power to detect a significant regression coefficient (α = 
.05) with a small effect size (f2 = .02) and over 99.9% power to detect a medium effect (f2 = 
.15).    
Measures   
Disgust Propensity and Sensitivity.  Participants’ overall DP and DS were measured 
using the 16-item Disgust Propensity and Sensitivity Scale-Revised (DPSS-R; van Overveld 
DISGUST AND CANCER STIGMA  9 
 
et al., 2006).  The measure uses a 5-point Likert scale (1 = never, 5 = always).  Example 
items include: “I avoid disgusting things” (DP) and “When I notice I feel nauseous, I worry 
about vomiting” (DS).  Based on psychometric evaluations of the DPSS-R (Goetz, Cougle, & 
Lee, 2013; Olatunji et al., 2007a), a recommended revised 10-item solution (four items for 
DS and six items for DP) was used for analyses.  The Cronbach’s alphas were α = .77 for DS 
and α = .81 for DP. 
We also measured participants’ DP to three different types of disgust elicitors (“core”, 
“animal-reminder”, and “contamination-based” disgust) using the 25-item Disgust Sensitivity 
Scale-Revised (DS-R; Haidt, McCauley, & Rozin, 1994; modified by Olatunji, Cisler, 
Deacon, Connolly, & Lohr, 2007b).  Results using these sub-domain scores, rather than the 
overall DP measure, are presented in the Supplementary Materials (Appendix A) for 
interested readers.       
Cancer Stigma.  Participants completed the 25-item Cancer Stigma Scale (CASS; 
Marlow & Wardle, 2014), which assesses multiple aspects of cancer stigma including: 
awkwardness (5-items, e.g. “I would find it hard to talk to someone with cancer”); severity 
(5-items, e.g. “Getting cancer means having to mentally prepare oneself for death”); 
avoidance (5-items, e.g. “If a colleague had cancer I would try to avoid them”); policy 
opposition (4-items, e.g. “The needs of people with cancer should be given top priority”); 
personal responsibility (4-items, e.g. “If a person has cancer it's probably their fault”); and 
financial discrimination (3-items, e.g. “It is acceptable for insurance companies to reconsider 
a policy if someone has cancer”).  Responses for each item were made on a 6-point Likert 
scale (1 = disagree strongly, 6 = agree strongly).  Cronbach's alpha scores were: severity: α = 
.66; personal responsibility: α = .88; awkwardness: α = .82; avoidance: α = .81; financial 
discrimination: α = .73; and policy opposition: α = .74. 
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 Demographic Questions.  Participants were asked about their age, gender (0 = 
female, 1 = male), ethnicity (recoded as 0 = not White British, 1 = White British), and 
education (highest level completed: 1 = Secondary Education or equivalent, 2 = 
Undergraduate Degree or equivalent, 3 = Masters Degree or equivalent, 4 = PhD or 
equivalent).     
Procedure 
Ethical approval was granted by the host institution prior to data collection.  Informed 
consent was obtained from all individual participants included in the study.  In the first 
instance, the link to the URL and the corresponding password were e-mailed to participants.  
To minimize response bias, participants were informed that the aim of the study was to 
investigate their attitudes towards health, and the full objectives of the study were only 
disclosed in the debriefing.  Participants were informed at the consent stage in the survey that 
they may be contacted after three days to take part in a related study (Phase 2) and were 
required to leave their email addresses if they consented to this.  A prize draw of £100 was 
offered for those who completed both study phases.  In Phase 1, participants completed the 
demographics questions and the measures outlined above in a counterbalanced order. 
Data analysis 
Following descriptive and correlational analyses in SPSS v. 22 (IBM Corp., Armonk, 
NY, US), multiple regression analyses were conducted on AMOS v. 22 (IBM Corp., 
Armonk, NY, US) to examine the predictive association of DP and DS with cancer stigma, 
and the difference between the DP and DS coefficients.  Bootstrapping was used to account 
for data with a non-normal distribution.  Bootstrapping provides a non-parametric robust 
alternative to parametric estimates when the assumptions of those methods may be violated 
(e.g., Fox, 2008).  The significance of all regression path coefficients was assessed by 
computing bias-corrected and accelerated bootstrap estimates with 95% confidence intervals 
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(BCa 95% CIs).  This technique was utilised because it performs optimally with regard to 
statistical power and type I error rates compared to other methods (Efron, 1987).  Ten 
thousand resamples were used for the bootstrapped estimates (Mallinckrodt, Abraham, Wei, 
& Russell, 2006).  Age, gender, education, and ethnicity were included as potential observed 
confounds in all regression models.   
Results 
Descriptive statistics and bivariate correlations among the disgust and stigma 
variables are presented in Table 1.  Central to the interests of this paper was whether disgust 
had a significant link with cancer stigma.  Initial correlational analyses showed that there 
were significant associations between DP with most of the study variables.  In particular, DP 
had significant positive associations with most of the CASS subscales: severity, r = .27, p < 
.001, awkwardness, r = .30, p < .001, and avoidance, r = .15, p = .013.  However, there was 
no significant correlation of DP with responsibility, discrimination, or policy opposition 
stigma.  DS was found to significantly correlate only with severity-based stigma, r = .13, p = 
.033.   
In the multiple regression models (Table 2), DP was found to be independently 
positively associated with severity, β = .26, p < .001, awkwardness, β = .33, p < .001, and 
avoidance, β = .16, p = .009.  However, there were no significant associations of DP with 
responsibility, discrimination, and policy opposition stigma.  Disgust sensitivity was not 
independently associated with any of the outcomes.  Disgust propensity had a significantly 
larger association than DS with awkwardness-based stigma, Δβ = .39, p = .002, and a 
borderline significant greater association with severity-based stigma, Δβ = .25, p = .052. 
Discussion 
Phase 1 of the study established that disgust traits have significant links with 
particular dimensions of stigma towards people with cancer, including awkwardness and 
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avoidance.  These findings support part of prediction (1), that individuals with a higher DP 
would report increased stigma towards people with cancer, and confirm previous findings 
(e.g., from Pryor et al., 2004).  These findings are also consistent with prior research 
demonstrating positive links between DP and negative attitudes towards marginalised 
outgroups, including obese people (e.g., Vartanian, 2010), homosexuals (e.g., Inbar et al., 
2009; Olatunji, 2008), and immigrants (e.g., Aarøe et al., 2017).  The present findings also 
show for the first time that DS (a trait related to, but independent from, DP) is not as 
important as DP in understanding individuals’ propensity to cancer stigma.  In particular, 
even after controlling for DS, DP had a significant independent association with three 
dimensions of stigma, while DS did not.  Furthermore, in partial support of prediction (2), DP 
had a significantly stronger effect than DS in one of these dimensions (awkwardness) and a 
borderline significantly larger effect in another (severity).   
These findings suggest that how easily people are disgusted may be more important 
for understanding cancer stigma than the extent to which people find the experience of 
disgust aversive (see e.g., van Overveld et al., 2006).  While further work may be necessary 
to elucidate these results, one interpretation is that individual differences in the threshold 
required for cancer to elicit disgust matters for understanding disgust-driven cancer stigma.  
In particular, not everyone will find cancer (and the stimuli they associate with it) disgusting, 
and those that do not will not be impacted by the extent of their sensitivity to the disgust 
experience.  Disgust sensitivity appears to play a stronger role in situations where disgust is 
universally experienced, such as avoiding vomit within emetophobia (or a fear of vomiting; 
van Overveld, de Jong, Peters, van Hout, & Bouman, 2008).  Further, people who have 
higher disgust propensity may exhibit stigma by wanting to avoid interactions with people 
with cancer that they find potentially disgust-provoking.  Previous research has shown that 
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disgust propensity is a better overall predictor of behavioural avoidance than disgust 
sensitivity (van Overveld, de Jong, & Peters, 2010).     
Disgust responses (in the form of DP) were associated with certain types of stigma 
and not others.  This pattern of associations makes sense, as DP was most strongly associated 
with dimensions of stigma that have been theoretically and empirically linked to disgust, 
including the associated behavioural response of avoidance (e.g., Reynolds, Lin et al., 2015); 
awkwardness around others with disease, including reduced approach and interactive 
behaviour (Hodson et al., 2013); and severity, which includes themes of death (i.e., “Getting 
cancer means having to mentally prepare oneself for death”) and irreversible contamination 
(i.e., “Once you’ve had cancer you can never be ‘normal’ again”).  These effects did not 
extend to other, less-related, and arguably more cognitive, forms of stigma, including 
perceived responsibility, financial discrimination, and policy opposition.       
These findings support the idea that stigma may be associated with a conservative 
defence against disease (via disgust responding), and individuals or situations that might 
result in contamination (e.g., Neuberg et al., 2011; Oaten, Stevenson, & Case, 2011; Schaller 
& Park, 2011).  However, a significant limitation of Phase 1 is that it only demonstrates 
associational relationships between DP and cancer stigma.  In addition to the hypothesised 
pathway, there are a number of possible reasons why covariation between these negative 
constructs could exist, including, for example, heightened trait affectivity.  Therefore, in the 
next phase of the work we sought to examine a potential causal mechanism between the two 
constructs through an experimental paradigm.  This experimental study aimed to explore the 
effect of being exposed to disgust-related cancer stimuli on reported avoidance- and 
awkwardness-based stigma, through the level of reported state disgust experienced, as a 
function of participants’ underlying disgust traits.  Avoidance- (Curtis et al., 2011; Pryor et 
al., 2004) and awkwardness- (Hodson et al., 2013) based reactions are commonly 
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theoretically and empirically linked to disgust and thus were deemed relevant to focus on as 
an experimental outcome variable.  They also have clear implications for behaviour, and were 
found to be significantly related to DP in Phase 1 (along with severity).       
Mediation and moderated-mediation path analyses were used to test the central 
interests in Phase 2 of the study.  These were: (a) to test experimentally a causal effect of 
exposure (i.e., exposure to disgust-related cancer stimuli) on stigma towards people with 
cancer, through reported state disgust responses; and (b) provide insight into the 
psychological mechanism explaining how individuals’ DP may lead to greater avoidance and 
awkwardness-based stigma via state disgust.  
Phase 2 – Experimental Study 
Methods 
Participants 
One hundred and forty-one participants were recruited from the sample in Phase 1.  
To ensure that a balanced number of subjects from various subgroups were selected, 
participants were stratified based on their age, gender, and DP scores, and then randomized to 
the experimental (cancer surgery video; n = 73) or control (neutral video, n = 68) condition.  
Most participants were women (n = 103), and participants’ ages ranged from 18 to 65 years 
(M = 27.45 SD = 10.15).  The study had greater than 80% power (as recommended by Cohen, 
1992) to detect a significant regression coefficient (α = .05) of a small-to-medium size (f2 = 
.05).  
Measures 
Avoidance- and Awkwardness-Based Stigma.  In order to index experimentally-
induced variation in stigma we designed a brief, 4-item Visual Analogue Scale (VAS) 
measure to use as the dependent variable (see Appendix B in the Supplementary Materials) 
adapted from the Cancer Stigma Scale (CASS; Marlow & Wardle, 2014).  To make a brief 
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VAS measure, suitable for use in an experimental paradigm, 4 items from 10 were randomly 
selected from the awkwardness and avoidance behaviour subscales.  The four items included 
were: “Responding honestly, I would try to avoid a person with cancer”, “I would find it 
difficult being around someone with cancer”, “I would find it hard to talk to someone with 
cancer”, and “I would distance myself physically from someone with cancer”.  Participants 
responded to each stem on a 100-point VAS (e.g., 0 = not at all, 100 = extremely so), and a 
mean score was calculated.  Factor analysis on these items revealed that they best loaded 
together as one factor (see Appendix C in the Supplementary Materials).  The Cronbach's 
alpha score for this measure was .85.  This 4-item measure was designed to minimise 
participant burden, while maximising variance through the use of a 100-point VAS. 
State Emotion.  In order to measure state disgust, a VAS (adapted from Powell, 
Simpson, & Overton, 2015) was used to record how much disgust participants felt after 
watching the videos.  As a manipulation check, participants also completed VASs for four 
other basic emotions (anger, sadness, fear, and happiness) after watching the videos (see 
Appendix D in the Supplementary Materials).  For each emotion, participants responded to 
the stem: “Responding honestly, how disgusted/angry/sad/afraid/happy did the video make 
you feel” on a 100-point VAS (e.g., 0 = not at all, 100 = extremely).   
Control Variables.  In order to better test the causal effect of exposure on state-
reported stigma, participants’ pre-existing level of stigma towards people with cancer (the 
combined scores of the 4-items on the CASS in Phase 1 that were used as the VAS stigma 
scale) was included as a covariate in the model. 
Experimental Stimuli.  We intended to select cancer-relevant disgust stimuli to 
reflect the proposed causal mechanism by which proneness to disgust might predict cancer 
stigma (i.e., via the disgust-induced by cancer stimuli).  A pilot study, with an independent 
sample (n = 10), was conducted to select suitable videos for the experimental study.  The link 
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to the URL and the corresponding password were e-mailed to ten postgraduate students in 
psychology.  Participants were asked to watch three freely-available videos thought a priori to 
be cancer-relevant and disgust eliciting (ovarian cancer surgery, 
https://youtu.be/SGV70h5ZFTM; liver cancer surgery, https://youtu.be/1J4kdRuHVeg; and 
ostomy care, https://youtu.be/LxkFTbQMvGo), and another three neutral videos (static traffic 
cone, https://youtu.be/pEll1YpSunc; crawling snail, https://youtu.be/VaLGV-SBTmc; and 
dripping tap, https://youtu.be/33NOQV0Soz8).  All videos were approximately three minutes 
long.       
The videos were administered in a counter-balanced order using Qualtrics.  Emotion 
VASs were recorded (as described above).  One additional scale assessing the distress level 
of each of the videos was also included.  Based on the results of this study (see Appendix E in 
the Supplementary Materials), the video which had been rated with the highest disgust rating 
was chosen for the experimental condition (ovarian cancer surgery), and the least disgusting 
video was chosen for the control condition (static traffic cone).   
Procedure 
 All Phase 1 participants who had left their contact details for further participation 
were invited to take part.  Informed consent was obtained from all individual participants 
included in the study.  Participants were exposed to a cancer surgery video or a neutral video 
through a Qualtrics link, which was sent by email three days after their survey study.  In 
order to ensure their attention and engagement with the videos, the participants were told that 
they would be asked a few memory questions related to the videos after watching them (e.g., 
“what was the human organ involved in the surgery?”), on which they did not receive 
feedback.  Participants then completed the VAS emotion measures and VAS stigma scale 
after they watched the video.  Finally, a positive video was offered to participants in the 
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experimental condition to help counterbalance the inherent negativity of the video (happy 
baby, https://youtu.be/bMME3wyB1zQ).  Participants were then debriefed. 
Data Analysis 
Following manipulation checks, path analysis with AMOS v. 22 (IBM Corp., 
Armonk, NY, US) was used to model the hypothesised causal relationships between the 
variables (i.e., mediation and moderated mediation models).  Path analysis has several 
advantages over standard multiple regressions, including the estimation of direct and indirect 
effects (through mediating variables) simultaneously. 
 An initial mediation model tested prediction (3), that exposure to disgust-related 
cancer stimuli (i.e., cancer surgery) would invoke state disgust responses, which would lead 
to increased stigma.  Variables included were experimental condition, DP, DS, and T1 
Stigma as exogenous predictors, disgust response as a hypothesized mediator, and VAS 
stigma as an outcome (see Figure 1).  In this model, parameter weights on condition*DP and 
condition*DS interaction terms were constrained to zero. 
 A moderated mediation model tested prediction (4), that DP or DS would have a 
causal effect on stigma by heightening (moderating) the level of disgust participants 
experienced as a consequence of exposure to disgust-related cancer stimuli.  In this model the 
parameter constraints on the condition*DP and condition*DS interaction terms were 
removed.  We included baseline (T1) stigma in the models to provide a stronger test of the 
experimental hypothesis (that cancer-relevant disgust exposure causes changes in stigma).  
Similar, stronger effects were observed if T1 Stigma was omitted from the models (for model 
estimates see Appendix F in the Supplementary Materials).   
 As in Phase 1, bootstrapping was used to estimate CIs and corresponding probability 
estimates, and to test the significance of indirect effects (Hayes & Scharkow, 2013).  To 
allow for inter-variable comparisons, prior to the analysis, continuous scores were 
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standardised based on Gelman (2008), where each numeric variable was centred and divided 
by two times its standard deviation, (comparable to an equally distributed binary variable).  
This also facilitated the use of an interaction term without any problematic multicollinearity. 
Results 
Randomisation and Manipulation Checks 
Experimental and neutral condition participants did not significantly differ on gender, 
χ2 (1) = 0.02, p = .901, Φ = .01; and age, t(139) = 0.52, p = .604, d = 0.09.  Moreover, there 
were no significant group differences in DP, t(139) = −1.02, p = .309, d = 0.17, or DS, t(139) 
= -0.93, p = .356, d = 0.16.  Thus, the randomisation of these characteristics between the two 
conditions was successful.  Those in the experimental condition reported significantly more 
disgust (M = 42.52, SD = 30.72) than those in the control condition (M = 2.04, SD = 3.70), 
t(74.24) = 11.17, p < .001, d = 1.85.  However, there were also, smaller, significant 
differences in the other emotions, potentially due to shared variance in the affective states.  
Accordingly, to calculate which emotion VASs were independently affected by the induction, 
a binary logistic regression was conducted, with all five emotion VASs regressed on group 
membership.  The model was significant, χ2(5) = 146.13, p < .001, explaining 86.1% 
(Nagelkerke R2) of the variance in group membership, correctly classifying 94.3% of cases.  
Group membership was independently explained by levels of disgust, b = 0.42, p < .001, 
anger, b = -0.48, p < .001, sadness, b = 0.15, p = .026, and happiness, b = 0.04, p = .024, but 
not fear, b = -0.06, p = .173.  Contrary to predictions, those in the experimental condition (M 
= 11.79, SD = 14.85) reported significantly lower stigma, on average, than those in the 
control condition (M = 17.59, SD = 17.69), t(131.235) = -2.10, p = .038, d = 0.36. 
Path Model   
The model fit for the mediation model was χ2(6) = 25.68, p < .001, CFI = .958, 
RMSEA = .15, BCa 95% CI [.10, .22], p = .003.  The model explained 52.4% of the variance 
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in VAS disgust and 48.2% in VAS stigma.  Being in the experimental condition had a direct 
negative effect on reported stigma, β = -.22, p = .002, and a direct positive effect on 
experienced disgust, β = .71, p < .001.  State disgust had a significant direct effect on 
reported stigma, β = .20, p = .011.  Accordingly, a significant positive indirect effect of 
condition on stigma was observed via experienced disgust, βab = .14, p = .011.         
The model fit for the moderated mediation model was χ2(4) = 6.47, p = .167, CFI 
= .995, RMSEA = .07, BCa 95% CI [.00, .16], p = .312, fitting significantly better than the 
mediation model, Δχ2 (2) = −19.21, p < .001.  The interaction between experimental 
condition and DP significantly predicted VAS disgust, β = .26, p = .001, and had a significant 
indirect effect on VAS stigma via experienced disgust, β = .05, p = .008.  Key path estimates 
and bootstrap SEs/CIs are presented in Table 3.   
To clarify further the nature of the moderating effect, the effect of experimental 
condition on stigma via experienced disgust was estimated at three levels of DP, at two 
standard deviations below the mean (low), at the mean (moderate), and two standard 
deviations above the mean (high).  Simple slopes analysis revealed that experimental 
assignment had a stronger indirect effect on VAS stigma, through experienced disgust, at 
higher levels of DP, with significant indirect effects at high, β = .22, p = .012, moderate, β 
= .14, p < .001, and low, β = .07, p = .008, levels of DP.   
Discussion   
 The primary findings from this experiment were that participants in the experimental 
condition who were exposed to the cancer surgery video were more likely to experience 
greater disgust.  Those experiencing greater disgust were also more likely to report greater 
avoidance- and awkwardness-based cancer stigma.  Furthermore, this mediation effect was 
moderated by trait DP: those with greater DP experienced greater disgust in response to the 
cancer surgery video, which led to a greater tendency for stigma towards people with cancer, 
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even while controlling for prior levels of stigma reported in the Phase 1 survey.  Interestingly, 
exposure to the cancer surgery video per se otherwise appeared beneficial, having a 
significant negative direct effect on reported VAS stigma.     
These results establish a potential causal role for DP in heightening cancer stigma by 
moderating the extent of disgust reactions to disgust-relevant cancer-related stimuli.  They 
extend previous work on disgust and negative attitudes (e.g., Inbar et al., 2009; Olatunji, 
2008), specifically towards people with chronic diseases (Pryor et al., 2004; Smith et al., 
2007; Vartanian, 2010).  We found support for prediction (4), that DP moderated state disgust 
in response to cancer stimuli, which lead to increased avoidance- and awkwardness-based 
cancer stigma responses.  However, the positive effect of experimental exposure on stigma 
(in the absence of a heightened disgust pathway) goes contrary to our initial prediction (3), as 
we discuss in the General Discussion below. 
General Discussion 
The present research examined the role of disgust in the stigmatization of people with 
cancer.  Findings of Phase 1 provided support for the idea that trait disgust (in the form of 
disgust propensity [DP]) had significant cross-sectional links with particular dimensions of 
stigma towards people with cancer, including avoidance- and awkwardness-based stigma.  
Phase 2 demonstrated the validity of a potential causal pathway for DP to act on cancer 
stigma via moderation of the experiential state disgust reactions following exposure to 
disgust-associated cancer stimuli.  
This study addressed significant gaps in the literature and has at least three valuable 
implications to assist with the development of effective interventions for reducing stigma 
towards people with cancer.  First, the findings suggest that trait disgust matters in 
understanding cancer stigma.  While relatively stable over time, trait DP is malleable, and 
may be altered via habituation with repeated (positive) exposure over time, particularly 
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within specific domains (e.g., Athey et al., 2015; Rozin, 2008).  Further, in attempting to 
reduce cancer stigma, potentially reducing available triggers for disgust in communications 
about cancer may be beneficial.  In supplementary domain specific analyses (see Appendix A 
in the Supplementary Materials), the moderating effect of DP was driven via “animal-
reminder” disgust.  This suggests that one possible way in reducing stigma might be to reduce 
the exposure to reminders of mortality through an increased awareness that cancer is a 
survivable disease (e.g., Greene & Adelman, 2003; Scheel et al., 2017).  Other counter-
disgust messages are possible, including emphasising that cancer is not contagious (as 
perceived transmissible disease is a trigger of disgust; Curtis et al., 2004).  Such content 
could be incorporated within broader public awareness campaigns or messages designed to 
reduce cancer stigma.      
Second, given the key role of state disgust in explaining the link between DP and 
reported stigma, methods of reducing state disgust after exposure to disgust-relevant cancer 
stimuli may be important.  It has been suggested that activated compassion (Gilbert, 2010) 
may promote acceptance and reduce disgust and threat systems in humans, and so inducing 
compassion in individuals also may be a solution to reduce stigma, by inducing incompatible 
or contrasting positive emotional reactions, as has been applied in relaxation therapy for 
anxiety (e.g., Pagnini, Manzoni, Castelnuovo, & Molinari, 2013).  Indeed, a recent 
experimental study showed that induced compassion may offset the disengagement in health 
care providers otherwise produced by patients with disgusting symptoms (Reynolds, Powell, 
Lin, Ravi, Chung, & Consedine, 2019).  Promoting positive emotions and minimising stigma 
is also a relevant concern for public awareness campaigns that, for example, seek to use 
disgust-based content to discourage health behaviour linked to cancer.  An example of this is 
the disgust content that features in anti-smoking campaigns, which may inadvertently 
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heighten disgust-based stigma for people with cancer types linked to smoking (Lupton, 
2014). 
As a complementary approach, efforts to reduce stigma may centre on processing 
negative emotions directly, such as by adapting in interventions the procedures used in 
Acceptance and Commitment Therapy (ACT), which has proven effective in previous studies 
(e.g., Luoma & Platt, 2015; Masuda et al., 2007; Skinta, Lezama, Wells, & Dilley, 2015).  
For example, Masuda et al. (2007) showed that an ACT workshop was more effective than 
education alone, in reducing mental health stigma in students.  The ACT workshop involved 
a number of complementary stages, including exercises for participants to notice how 
judgemental processes are automatic, prevalent and related to mental health stigma; the use of 
data (evidence) to normalise psychological struggles; exercises focusing on empathy and 
parallel reactions to others versus the self; training in acceptance and non-judgemental skills; 
and a behavioural commitment to the area of interpersonal relationships.  Similar techniques 
could be adapted for use in addressing disgust-induced cancer stigma.  Further, considering 
the intense negative affective experience, training in distress tolerance or emotion regulation 
(Gayner et al., 2012), which has proven effective in reducing self-stigma, may be potentially 
useful for individuals with pronounced disgust, in combating external stigma. 
Third, an interesting finding from this study is that, in the absence of disgust, 
exposure to a disgust-relevant cancer surgery video induced less reported stigma relative to 
those exposed to a neutral video, when controlling for prior levels of stigma.  Therefore, 
exposure to cancer-relevant stimuli without an accompanying disgust reaction may be 
effective for reducing stigma.  A number of explanatory possibilities are relevant here, 
including that participants experienced empathetic and prosocial reactions, including 
compassion and sympathy, in response to the cancer surgery video.  Alternatively, the video 
may have conferred some educational benefits for participants on a cancer patient’s 
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experience.  The result also validates previous work and psychological therapies that 
incorporate exposure in reducing stigma (e.g., positive interpersonal contact with transgender 
individuals is associated with lower sexual stigma and prejudice, Walch et al., 2012).  This 
also may suggest that exposure could be beneficial in reducing stigma towards people with 
cancer, in the absence of disgust or related negative emotions (e.g., through the 
implementation of graded exposure or incompatible positive emotions, such as compassion or 
relaxation).  The gradual exposure-based interventions (which are based on the systematic 
exposure to the feared stimulus, either in the imagination or real contact), for instance, may 
help individuals down-regulate negative emotion while learning to tolerate provocative 
unpleasant emotion-inducing stimuli, until the negative feeling decreases and eventually 
extinguishes (e.g., Grecucci, Theuninck, Frederickson, & Job, 2015). 
Limitations and Ideas for Future Research 
One limitation of this present study is that it is based on self-reported levels of disgust 
and stigma, rather than observed behaviour.  Accordingly, there is the possibility of bias 
between what participants’ self-report and what would be observed behaviourally (i.e., in 
behavioural tests of stigmatization).  Alternative methods may be considered that involve 
behavioural assessments of avoidance-based stigma, such as a Behavioural Avoidance Task 
(e.g., Reynolds, Consedine, & McCambridge, 2014).  Nevertheless, self-report measures are 
often well-correlated with actual behaviour, and so should be considered indicative of what 
may be expected in behavioural studies (e.g., Wash, Rader, & Fennell, 2017).  Second, the 
stimuli used to elicit disgust in Phase 2 (i.e., cancer surgery) may have more relevance to the 
animal-reminder disgust domain than other domains of disgust.  Therefore, future research 
could potentially include broader stimuli that may elicit other domains of disgust (e.g., 
contamination threats via a dirtied stoma bag) to test for the versatility of effects.  This may 
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include tests of whether similar effects are observed using non-cancer-relevant disgust stimuli 
and experience states. 
A third limitation arises from the lack of attention towards the underlying complex 
variation of stigma towards different cancer types.  Certain cancer types may elicit different 
dimensions of stigma (e.g., lung cancer has been identified to be highly associated with 
responsibility stigma as its established link with smoking mean that it is perceived to be 
personally controllable; Marlow, Waller, & Wardle, 2015).  Therefore, in future work, the 
causal path model could be expanded to examine stigma specific to cancer types.  A further 
limitation in this study is, in the experimental phase, the work only focused on awkwardness- 
and avoidance-based stigma, which have been theoretically and empirically related to disgust.  
Future studies may involve extensions to more holistic or broader dimensions of stigma.  A 
fifth limitation is the absence of a negative affect experimental control group in Phase 2 (e.g., 
an anxiety or embarrassment induction), which would allow an examination of whether the 
observed effects on stigma are specific to a disgust induction paradigm.  Additional affective 
control groups could be incorporated in future work.  Finally, the sample was predominantly 
female and so it is unclear whether similar effects would be seen in men, although the effects 
of gender on stigma in this study were small. 
Conclusion 
In conclusion, this is the first study to demonstrate a potential causal mechanism for 
underlying disgust traits to produce cancer stigma, through heightened state disgust reactions 
via cancer-relevant exposure (when controlling for prior levels of stigma).  Disgust 
propensity but not DS seems uniquely relevant in understanding propensity to cancer stigma.  
These results help to understand the mechanisms and natural consequences of disgust as an 
overly-conservative behavioural immune system, which may lead to stigma towards people 
with chronic illnesses, such as cancer, via exposure to disgust-eliciting cancer stimuli.  It is 
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therefore suggested that efforts to reduce cancer stigma should put more emphasis on 
underlying DP as a predictor, and should focus on reducing state disgust following the 
exposure to cancer-relevant stimuli, to create more positive exposure experiences. 
 
Ethical approval: All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional research committee (name of 
committee blinded for peer review) and with the 1964 Helsinki declaration and its later 
amendments or comparable ethical standards. 
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Figure 1. Moderated mediation model between Condition and VAS Stigma via VAS disgust. 
Propensity to disgust significantly moderated the effect of condition on VAS disgust, β = .26, p < .01, and thus the strength of the causal 
mediational pathway of condition on VAS stigma via VAS disgust. Correlations between exogenous predictors and error terms omitted for 
clarity. The estimates in the brackets represent the estimates in the mediation model (with interaction terms constrained to 0). All estimates are 
standardised betas (β). Significance levels were determined based on bootstrapped CIs (10,000 resamples). DP = disgust propensity; DS = 
disgust sensitivity; T1 stigma = trait stigma composite in Phase 1.  Asterisked coefficients are significant at †p < .10. *p < .05. **p < .01. ***p 
< .001.   
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Table 1. Bivariate correlation coefficients (Pearson’s r) among study variables in Phase 1. 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. Age —               
2. Gender  .04 —              
3. Education   .35*** −.08 —             
4. Ethnicity  .05 .05 −.04 —            
5. DPSS-R DP −.17** −.02 −.19** −.02 —           
6. DPSS-R DS −.20** −.09 −.13* −.09 .48*** —          
7. DS-R Core −.09 −.30*** −.10† −.20** .53*** .40*** —         
8. DS-R AR −.24*** −.21** −.08 −.16** .41*** .43*** .58*** —        
9. DS-R CB −.10 −.12† −.13* −.33*** .38*** .31*** .58*** .46*** —       
10. Severity −.07 .11† −.09 .04 .27*** .13* .25*** .15* .21** —      
11. Responsibility −.13* .08 .01 −.21*** .10† .07 .14* .12* .24*** .22*** —     
12. Awkwardness −.10† .03 −.00 −.14* .30*** .11† .24*** .36*** .17** .38*** .19** —    
13. Avoidance −.02 .05 .01 −.09 .15* .08 .16** .22*** .18** .29*** .27*** .55*** —   
14. Discrimination −.08 .03 .00 .03 .01 −.04 −.04 −.04 −.04 .26*** .26*** .20** .23*** —  
15. Policy opposition −.14* −.03 −.05 .01 −.04 −.09 −.19** −.11† −.14* −.06 .14* −.01 .10† .22*** — 
M 26.72 0.28 1.81 0.59 16.79 9.60 24.21 13.86 5.44 3.05 1.60 2.20 1.29 2.14 2.23 
SD 10.71 0.45 0.89 0.49 3.73 3.46 8.57 6.69 3.65 0.87 0.85 0.96 0.49 1.04 0.91 
Note. N = 272.  Correlations represent Pearson’s r, pointbiseral (rpb), or phi (rΦ) coefficients.  DPSS-R = Disgust Propensity and Sensitivity 
Scale-Revised (van Overveld et al., 2006); DP = disgust propensity subscale; DS = disgust sensitivity subscale; DS-R = Disgust Scale-Revised 
(Haidt et al., 1994; Olatunji et al., 2007b); Core = core disgust subscale; AR = animal reminder disgust subscale, CB = contamination-based 
disgust subscale.  Items 10 to 15 are the subscales from the Cancer Stigma Scale (Marlow & Wardle, 2014).  Values for gender: 0 = female; 1= 
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Table 2. Regression analyses of disgust propensity and sensitivity predicting stigma towards people with cancer. 
Note. N = 272.  DP = disgust propensity; DS = disgust sensitivity; DP v. DS = difference in regression path for DP versus DS; BCa 95% CI = 
Bias-corrected and accelerated bootstrapped 95% confidence interval; LL = lower limit; UL = upper limit; SE = bootstrapped standard error for B.  
Unadjusted R2 reported.  aLower BCa 95% CI was not computed.  Asterisked coefficients are significant at †p < .10. *p < .05. **p < .01. ***p 
< .001.
 Stigma dimension 
 Severity Responsibility Awkwardness Avoidance 
Variable B [BCa 95% CI] SE β B[BCa 95% CI] SE β B[BCa 95% CI] SE β B[BCa 95% CI] SE β 
Gender 0.22 [−0.00, 0.46] 0.12 .12† 0.19 [−0.04, 0.45] 0.12 .10 0.11 [−0.13, 0.36] 0.13 .05 0.06 [−0.06, 0.19] 0.06 .06 
Age −0.00 [−0.01, 0.01] 0.01 −.02 −0.01 [−0.02, −0.00] 0.00 −.14** −0.01 [−0.02, 0.00] 0.01 −.08 0.00 [−0.01, 0.01] 0.00 −.00 
Education −0.02 [−0.14, 0.10] 0.06 −.02 0.07 [−0.05, 0.21] 0.07 .08 0.08 [−0.06, 0.22] 0.07 .08 0.02 [−0.04, 0.08] 0.03 .04 
Ethnicity 0.08 [−0.13, 0.29] 0.11 .04 −0.35 [−0.57, −0.15] 0.11 −.20** 
−0.27 [−0.48, 
−0.05] 0.11 −.14* −0.09 [−0.21, 0.03] 0.06 −.09 
DP 0.06 [0.03, 0.09] 0.02 .26*** 0.02 [−0.01, 0.05] 0.02 .09 0.08 [0.05, 0.12] 0.02 .33** 0.02 [0.01, 0.04] 0.01 .16** 
DS 0.00 [−0.03, 0.04] 0.02 .01 0.00 [−0.03, 0.04] 0.02 .00 −0.02 [−0.05, 0.02] 0.02 −.06 0.00 [−0.02, 0.02] 0.01 .00 
DP v. DS 0.06 [0.00, 0.11] 0.03 .25† 0.02 [−0.04, 0.08] 0.03 .09 0.10 [0.04, 0.16] 0.03 .39** 0.02 [−0.01, 0.05] 0.01 .16 
Total R2 .09 [.03, .14]* .09 [.03, .14]* .12 [.05, .18]** .03 [.00, .06]* 
F 4.31 3.74 6.04 1.55 
 Discrimination Policy opposition   
Variable B [BCa 95% CI] SE β B[BCa 95% CI] SE β     
Gender 0.06 [−0.23, 0.36] 0.15 .03 −0.08 [−0.31, 0.17] 0.12 −.04     
Age −0.01 [−0.02, 0.00] 0.01 −.10† −0.01 [−0.03, 0.00] 0.01 −.16*     
Education 0.05 [−0.10, 0.20] 0.08 .04 −0.02 [−0.17, 0.12] 0.07 −.02     
Ethnicity 0.06 [−0.20,  0.32] 0.13 .03 0.01 [−0.22, 0.25] 0.12 .01     
DP 0.01 [−0.03, 0.05] 0.02 .04 −0.00 [−0.03, 0.03] 0.02 −.01     
DS −0.02 [−0.06, 0.02] 0.02 −.06 −0.03 [−0.07, 0.01] 0.02 −.12†     
DP v. DS 0.03 [−0.04, 0.10] 0.04 .10 0.03 [−0.03, 0.09] 0.03 .11     
Total R2 .01 […, .02]a .04 [.00, .07]*   
F 0.53 1.70   
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Table 3. Standardised direct and indirect effects and 95% confidence intervals for the 
mediation and moderated mediation models in Phase 2. 
Model pathways Estimates 
 
SE 
BCa 95% CI 
LL UL 
Step 1. Mediation model. χ2(6) = 25.68***, CFI = .958, RMSEA = .15** 
Direct effects 
Condition  VAS disgust .71*** .04 .64 .78 
Condition  VAS stigma −.22** .07 −.34 −.09 
VAS disgust  VAS stigma .20* .08 .05 .36 
DP  VAS disgust .11 .07 −.02 .25 
DS  VAS disgust .13* .06 .01 .25 
T1 stigma  VAS disgust  .13† .07 −.01 .28 
T1 stigma  VAS stigma .63*** .07 .48 .75 
Indirect effects 
Condition  VAS disgust  VAS stigma .14* .06 .03 .26 
DP  VAS disgust  VAS stigma .02† .02 .00 .07 
DS  VAS disgust  VAS stigma .03* .02 .00 .07 
T1 stigma  VAS disgust  VAS stigma .03* .02 .00 .08 
Step 2. Moderated mediation model. χ2(4) = 6.47, CFI = .995, RMSEA = .07 
Direct effects 
Condition x DP  VAS disgust  .26*** .08 .11 .41 
Condition x DS  VAS disgust .14 .08 −.03 .30 
Indirect effects 
Condition x DP  VAS disgust  VAS stigma .05** .03 .01 .12 
Condition x DS  VAS disgust  VAS stigma .03† .02 .00 .09 
Simple effects     
Condition  VAS disgust  VAS stigma (at low DP) .07** .04 .01 .18 
Condition  VAS disgust  VAS stigma (at moderate DP) .14* .06 .03 .26 
Condition  VAS disgust  VAS stigma (at high DP) .22* .09 .05 .40 
Note. N = 141. DP = disgust propensity; DS = disgust sensitivity; BCa 95% CI = Bias-corrected 
and accelerated bootstrapped 95% confidence interval; LL = lower limit; UL = upper limit; SE 
= bootstrapped standard error; T1 stigma = trait stigma composite in Phase 1.  Asterisked 
coefficients are significant at †p < .10. *p < .05. **p < .01. ***p < .001.  
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Appendix A. Analysis Using Disgust Subdomains 
Subdomain Disgust Propensity   
Participants’ propensity to three different types of disgust elicitors was measured 
using the 25-item Disgust Sensitivity Scale-Revised (DS-R; Haidt et al., 1994; modified by 
Olatunji, Cisler, Deacon, Connolly, & Lohr, 2007b).  This measures proneness to disgust in 
three domains: “core” (12 items measuring basic disgust elicitors such as vomit); 
“contamination-based” (CB; 5 items measuring interpersonal contagion threats such as 
touching a toilet seat in a public restroom); and “animal-reminder” (AR; 8 items measuring 
revulsion at reminders of our animal nature such as corpses or ashes of a person who has 
been cremated).  The measure uses a 5-point Likert scale from 0 to 4 for all items (0 = 
strongly disagree, 4 = strongly agree).  The Cronbach's alpha coefficients in the current study 
were α = .79 for the core, α = .77 for the AR and α = .59 for the CB subscales. 
Phase 1 Results   
The DS-R domain-specific subscales were significantly correlated positively with 
severity, core, r = .25, p < .01, AR, r = .15, p < .05, and CB, r = .21, p < .01; responsibility, 
core, r = .14, p < .05, AR, r = .12, p < .05, and CB, r = .24, p < .01; awkwardness, core, r = 
.24, p < .01, AR, r = .36, p < .01, and CB, r = .17, p < .01; and avoidance, core, r = .16, p < 
.01, AR, r = .22, p < .01, and CB, r = .18, p < .01, stigma on the Cancer Stigma Scale (CASS; 
Marlow & Wardle, 2014).  None of them significantly correlated with discrimination, and 
only core and CB disgust were found to be significantly correlated with policy opposition, 
core, r = −.19, p < .01, and CB, r = −.14, p < .05, however the correlations were in a negative 
direction.   
To identify whether high propensity in response to specific stimuli (core, AR, and/or 
CB disgust) significantly predicted stigma, models with the DS-R rather than the DPSS-R as 
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the measure of disgust, with core, AR, and CB as predictors were tested.  In these models, 
each trait of core, AR, and CB emerged as a significant predictor of different subscales of the 
CASS.  Core disgust exclusively predicted severity in a positive direction, β = .26, p < .01.  
Core disgust also predicted policy opposition, but in a negative direction, β = −.19, p < .05.  
Animal reminder exclusively predicted awkwardness, β = .33, p < .01, and avoidance, β = 
.18, p < .05.  Contamination based disgust exclusively predicted responsibility, β = .18, p < 
.05.  There were no significant effects on discrimination.  The results of these regression 
analyses are presented in Table A.1. 
Phase 2 Results   
Experimental and neutral condition participants did not significantly differ on DS-R 
scores, t(139) = -0.23, p = .821, d = 0.04, or any of the subscales.  In two separate analyses 
we tested both previous mediation and moderated mediation models with the DS-R rather 
than the DPSS-R as the measure of disgust propensity, with core, AR, and CB as predictors.  
The model fit for the data was, χ2 (9) = 32.88, p = .000; CFI = 0.967, RMSEA = .14, BCa 
90% CI [.09, .19], p = .003.  The model explained 57.2% (unadjusted) of the variance in VAS 
disgust and 48.2% (unadjusted) in VAS stigma.  Being in the experimental condition had a 
direct negative effect on reported stigma, β = -.22, p = .002, and a direct positive effect on 
experienced disgust, β = .70, p < .001.  State disgust had a significant direct effect on 
reported stigma, β = .20, p = .011.  Accordingly, a significant positive indirect effect of 
condition on stigma was observed via experienced disgust, βab = .14, p = .011.         
The model fit for the moderated mediation model was χ2(6) = 7.98, p = .240, CFI 
= .997, RMSEA = .05, BCa 90% CI [.00, .13], p = .439, fitting significantly better than the 
mediation model, Δχ2 (3) = −24.90, p < .001.  The interaction between experimental 
condition and AR disgust significantly predicted VAS disgust, β = .34, p < .001, and had a 
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significant indirect effect on VAS stigma via state disgust, β = .07, p = .007.  Key path 
estimates and bootstrap SEs/CIs are presented in Table A.2. 
To clarify the nature of the moderating effect, the effect of group condition on the 
mediator (experienced disgust), then leading to stigma, was estimated at three levels of AR at 
two standard deviations below the mean (low), at the mean, and two standard deviations 
above the mean (high).  Simple slopes analysis revealed that condition significantly predicted 
stigma, through VAS disgust, at high, β = .71, p < .001, and moderate, β = .69, p < .001, but 
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Table A.1. Regression analyses of subdomains of disgust propensity predicting stigma towards people with cancer. 
Note. N = 272.  Core = core disgust; AR = animal-reminder disgust; CB = contamination-based disgust; BCa 95% CI = Bias-corrected and 
accelerated bootstrapped 95% confidence interval; LL = lower limit; UL = upper limit; SE = bootstrapped standard error for B.  Unadjusted R2 
reported.  aBCa 95% CIs were not computed.  Asterisked coefficients are significant at †p < .10. *p < .05. **p < .01. ***p < .001. 
 Stigma dimension 
 Severity Responsibility Awkwardness Avoidance 
Variable B [BCa 95% CI] SE β B[BCa 95% CI] SE β B[BCa 95% CI] SE β B[BCa 95% CI] SE β 
Gender 0.38 [0.14, 0.62] 0.12 .20** 0.24 [0.01, 0.52] 0.13 .13* 0.30 [0.05, 0.55] 0.13 .14* 0.12 [−0.01, 0.26] 0.07 .11† 
Age −0.00 [−0.01, 0.01] 0.01 −.04 −0.01 [−0.02, −0.00] 0.00 −.14* −0.00 [−0.01, 0.01] 0.01 −.04 0.00 [−0.01, 0.01] 0.00 .02 
Education −0.01 [−0.13, 0.11] 0.06 −.01 0.09 [−0.03, 0.22] 0.06 .09 0.05 [−0.08, 0.18] 0.07 .05 0.02 [−0.04, 0.08] 0.03 .04 
Ethnicity 0.22 [0.01, 0.43] 0.11 .12* −0.24 [−0.46, −0.03] 0.11 −.14* −0.18 [−0.39, 0.04] 0.11 −.09 −0.03 [−0.16, 0.09] 0.06 −.03 
Core 0.03 [0.01, 0.04] 0.01 .26** 0.01 [−0.01, 0.02] 0.01 .05 0.01 [−0.00, 0.03] 0.01 .11 0.00 [−0.01, 0.01] 0.01 .04 
AR 0.00 [−0.02, 0.02] 0.01 −.00 −0.00 [−0.02, 0.02] 0.01 −.02 0.05 [0.03, 0.07] 0.01 .33*** 0.01 [0.00, 0.03] 0.01 .18* 
CB 0.03 [−0.01, 0 .06] 0.02 .11 0.04 [0.01, 0.08] 0.02 .18* −0.02 [−0.05, 0.02] 0.02 −.07 0.01 [−0.01, 0.03] 0.01 .08 
Total R2 .12 [.05, .18]** .11 [.04, .17]** .16 [.07, .22]** .07 [.01, .11]* 
F 5.08 4.51 7.15 2.72 
 Discrimination Policy opposition   
Variable B [BCa 95% CI] SE β B[BCa 95% CI] SE β     
Gender 0.05 [−0.27, 0.35] 0.16 .02 −0.19 [−0.43, 0.06] 0.12 −.10     
Age −0.01 [−0.02, 0.00] 0.01 −.10 −0.01 [−0.02, −0.00] 0.01 −.16†     
Education 0.04 [−0.10, 0.20] 0.08 .04 −0.04 [−0.19, 0.10] 0.07 −.04     
Ethnicity 0.05 [−0.21, 0.33] 0.14 .03 −0.07 [−0.32, 0.16] 0.12 −.04     
Core −0.00 [−0.02, 0.02] 0.01 −.01 −0.02 [−0.04, 0.00] 0.01 −.19*     
AR −0.01 [−0.03, 0.02] 0.01 −.04 −0.01 [−0.03, 0.01] 0.01 −.04     
CB −0.00 [−0.05, 0.05] 0.02 −.01 −0.01 [−0.05, 0.02] 0.02 −.05     
Total R2 .01 […, …]a .07 [.02, .12]*   
F 0.42 2.96   
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Table A.2. Standardised direct and indirect effects and 95% confidence intervals for the 
mediation and moderated mediation models in Phase 2 using disgust subdomains. 
Model pathways Estimates 
 
SE 
BCa 95% CI 
LL UL 
Step 1. Mediation model. χ2(9) = 32.88***, CFI = .967, RMSEA = .14** 
Direct effects 
Condition  VAS disgust .70*** .04 .62 .77 
Condition  VAS stigma −.22** .07 −.34 −.09 
VAS disgust  VAS stigma .20* .08 .05 .36 
Core  VAS disgust .12† .07 −.02 .26 
AR  VAS disgust .28*** .07 .14 .40 
CB  VAS disgust −.16* .07 −.30 −.02 
T1 stigma  VAS disgust  .11† .07 −.02 .25 
T1 stigma  VAS stigma .63*** .07 .48 .75 
Indirect effects 
Condition  VAS disgust  VAS stigma .14* .06 .03 .26 
Core  VAS disgust  VAS stigma .02† .02 .00 .07 
AR  VAS disgust  VAS stigma .06** .02 .02 .12 
CB  VAS disgust  VAS stigma −.03* .02 −.08 −.01 
T1 stigma  VAS disgust  VAS stigma .02† .02 .00 .07 
Step 2. Moderated mediation model. χ2(6) = 7.98, CFI = .997, RMSEA = .05 
Direct effects 
Condition x Core  VAS disgust  .17† .10 −.01 .38 
Condition x AR  VAS disgust .34*** .09 .16 .50 
Condition x CB  VAS disgust −.18† .09 −.37 .00 
Indirect effects 
Condition x Core  VAS disgust  VAS stigma .03* .03 .00 .11 
Condition x AR  VAS disgust  VAS stigma .07** .03 .02 .14 
Condition x CB  VAS disgust  VAS stigma −.04* .02 −.10 .00 
Simple effects     
Condition  VAS disgust  VAS stigma (at low AR) .05* .04 .01 .14 
Condition  VAS disgust  VAS stigma (at moderate AR) .14* .06 .03 .26 
Condition  VAS disgust  VAS stigma (at high AR) .23* .09 .06 .43 
Note. N = 141. Core = core disgust; AR = animal-reminder disgust; CB = contamination-based 
disgust; BCa 95% CI = Bias-corrected and accelerated bootstrapped 95% confidence interval; 
LL = lower limit; UL = upper limit; SE = bootstrapped standard error; T1 stigma = trait stigma 
composite in Phase 1.  Asterisked coefficients are significant at †p < .10. *p < .05. **p < .01. 
***p < .001. 
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Appendix B. Visual Analogue Scale Avoidance- and Awkwardness-Based Stigma - 
Adapted from the Cancer Stigma Scale (CASS; Marlow, & Wardle, 2014) 
 
Please indicate your answer by placing a cross along the 0 – 100 scale. 
 
Responding honestly, I would try to avoid a person with cancer 
  
                      0                                                 50              100   
         Not agree at all                                             completely agree 
 
I would find it difficult being around someone with cancer 
  
                      0                                                 50              100   
          Not agree at all                                             completely agree 
 
I would find it hard to talk to someone with cancer 
  
                      0                                                 50              100   
          Not agree at all                                             completely agree 
 
I would distance myself physically from someone with cancer 
  
                      0                                                 50              100   
           Not agree at all                                             completely agree 
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Appendix C. Principal Components Analysis of the Items Used to Form the VAS Stigma 
Composite for the Experimental Phase of the Research 
 
Table C.1. Principal Components Analysis of the VAS stigma composite. 
Component Matrix 
 Phase 1 loadings Phase 2 loadings 





I would try to avoid a person with cancer. .884 
I would find it difficult being around someone with cancer. .880 
I would distance myself physically from someone with 
cancer. 
.849 
Variance explained (%) 65.06 73.11 
Notes. N = 141.  Only one component was extracted.  The solution cannot be rotated. 
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Appendix D. Visual Analogue Scale Basic Emotion - Adapted from Powell et al. (2015) 
 
Please indicate your answer by placing a cross along the 0 – 100 scale. 
 
After watching the video, I am feeling… 
 
  
                      0                                                 50              100   
         Not at all disgusted                                             extremely disgusted 
 
  
                      0                                                 50              100   
         Not at all angry                                             extremely angry 
 
  
                      0                                                 50              100   
         Not at all sad                                             extremely sad 
 
  
                      0                                                 50              100   
         Not at all fear                                            extremely fear 
 
  
                      0                                                 50              100   
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Appendix E. Ratings for Videos in the Pilot Study 
 
Table E.1. Mean emotion ratings for videos in the pilot study. 
Video Disgust Fear Angry Sad Happy Distress 
Ovarian cancer surgery 81.0 35.0 9.6 9.5 0.6 70.0 
Liver cancer surgery 51.4 31.0 6.8 26.3 0.4 47.0 
Ostomy care 19.9 8.3 0.7 4.1 9.5 18.1 
Static traffic cone 0.6 1.8 21.6 0.5 0.7 18.2 
Crawling snail 1.6 2.2 8.8 0.3 17.3 22.9 
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Appendix F. Path Analysis without Baseline (T1) Stigma 
Baseline stigma (T1) was included as a covariate in the Phase 2 path model, here we report 
comparable estimates from a “post-measure only” (T2 Stigma only) design. 
 
Table F.1. Standardised effects in the primary (DPSS-R) path models with and without 
baseline (T1) stigma in the model.  
Model pathways 
Estimates (with T1 
Stigma in model) 
Estimates (without 
T1 Stigma in model) 
Model 1   
Condition  VAS disgust .71*** .70*** 
Condition  VAS stigma −.22** −.44*** 
VAS disgust  VAS stigma .20* .39*** 
DP  VAS disgust .11 .15** 
DS  VAS disgust .13* .12* 
Condition  VAS disgust  VAS stigma .14* .27*** 
DP  VAS disgust  VAS stigma .02† .06** 
DS  VAS disgust  VAS stigma .03* .05* 
Model 2   
Condition x DP  VAS disgust  .26*** .26** 
Condition x DS  VAS disgust .14 .14 
Condition x DP  VAS disgust  VAS stigma .05** .10** 
Condition x DS  VAS disgust  VAS stigma .03† .05† 
Simple effects   
Condition  VAS disgust  VAS stigma (at low DP) .07** .13** 
Condition  VAS disgust  VAS stigma (at moderate DP) .14* .27*** 
Condition  VAS disgust  VAS stigma (at high DP) .22* .41*** 
Note. N = 141. DP = disgust propensity; DS = disgust sensitivity.  Asterisked coefficients are 
significant at †p < .10. *p < .05. **p < .01. ***p < .001. 
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Table F.2. Standardised effects in the domain-specific (DS-R) path models with and 
without baseline (T1) stigma in the model.  
Model pathways 
Estimates (with T1 
Stigma in model) 
Estimates (without 
T1 Stigma in model) 
Model 1   
Condition  VAS disgust .70*** .68*** 
Condition  VAS stigma −.22** −.44*** 
VAS disgust  VAS stigma .20* .39*** 
Core  VAS disgust .12† .13† 
AR  VAS disgust .28*** .29*** 
CB  VAS disgust −.16* −.16* 
Condition  VAS disgust  VAS stigma .14* .27*** 
Core  VAS disgust  VAS stigma .02† .05* 
AR  VAS disgust  VAS stigma .06** .12*** 
CB  VAS disgust  VAS stigma −.03* −.06* 
Model 2   
Condition x Core  VAS disgust  .17† .15 
Condition x AR  VAS disgust .34*** .34** 
Condition x CB  VAS disgust −.18† −.16† 
Condition x Core  VAS disgust  VAS stigma .03* .06† 
Condition x AR  VAS disgust  VAS stigma .07** .13*** 
Condition x CB  VAS disgust  VAS stigma −.04* −.06* 
Simple effects   
Condition  VAS disgust  VAS stigma (at low AR) .05* .08† 
Condition  VAS disgust  VAS stigma (at moderate AR) .14* .27*** 
Condition  VAS disgust  VAS stigma (at high AR) .23* .45*** 
Note. N = 141. Core = core disgust; AR = animal-reminder disgust; CB = contamination-based 
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